•  
  •  
  •  
  •  

2025-12-23 14:29:25

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  SalesPerformance

Stock Report

  • Atul Auto Ltd reports 5.08% YoY growth in October 2025 sales volume
  • Eicher Motors Limited announces 7.3% YoY increase in sales for May 2025
  • Steel Strips Wheels Ltd announces performance for August 2024
  • JLR India announced a strong start to FY25
  • Atul Auto Ltd reports 18.10% YoY growth in sales for September 2023
  • Puravankara displays strong performance in Q1, records Rs. 1,126 crores in sale value
  • ATUL Auto Ltd announces sales of 1267 vehicles June 2023
  • Rama Steel Tubes Ltd announces sales performance for Q3FY23
  • Bajaj Auto's February 2022 sales down 16% YoY
  • Bajaj Auto posts 15% YoY fall in January 2022 sales volume

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024